# REN Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ren-pharmaceuticals

- Industry: Biotechnology
- Headquarters: New Haven, US
- Total disclosed funding: $6.3M
- Latest round: Series A (Jun 17, 2008)
- Investors on record: 4

## About

Founded in 2008 and based in New York, US, REN Pharmaceuticals, Inc. operates as a biotechnology company that provides therapies for the treatment of kidney and cardiovascular diseases.

## Funding rounds

- Series A, Jun 17, 2008, $5.3M — Sanderling Ventures, Venrock, Yale University, Amgen Inc.
- Series A, Nov 7, 2006, $1.1M — Sanderling Ventures, Venrock, Yale University, Amgen Inc.

## Investors

- Sanderling Ventures (https://capitalatlas.ai/funds/sanderling-ventures) — Series A
- Venrock (https://capitalatlas.ai/funds/venrock) — Series A
- Yale University — Series A
- Amgen Inc. — Series A